These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 37419331)

  • 21. Mulberry fruit ameliorates Parkinson's-disease-related pathology by reducing α-synuclein and ubiquitin levels in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model.
    Gu PS; Moon M; Choi JG; Oh MS
    J Nutr Biochem; 2017 Jan; 39():15-21. PubMed ID: 27741433
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cystatin C as a potential therapeutic mediator against Parkinson's disease via VEGF-induced angiogenesis and enhanced neuronal autophagy in neurovascular units.
    Zou J; Chen Z; Wei X; Chen Z; Fu Y; Yang X; Chen D; Wang R; Jenner P; Lu JH; Li M; Zhang Z; Tang B; Jin K; Wang Q
    Cell Death Dis; 2017 Jun; 8(6):e2854. PubMed ID: 28569795
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synaptojanin1 deficiency upregulates basal autophagosome formation in astrocytes.
    Pan PY; Zhu J; Rizvi A; Zhu X; Tanaka H; Dreyfus CF
    J Biol Chem; 2021 Jul; 297(1):100873. PubMed ID: 34126070
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Astrocyte-specific overexpression of Nrf2 delays motor pathology and synuclein aggregation throughout the CNS in the alpha-synuclein mutant (A53T) mouse model.
    Gan L; Vargas MR; Johnson DA; Johnson JA
    J Neurosci; 2012 Dec; 32(49):17775-87. PubMed ID: 23223297
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuroprotective effects of protocatechuic aldehyde against neurotoxin-induced cellular and animal models of Parkinson's disease.
    Zhao X; Zhai S; An MS; Wang YH; Yang YF; Ge HQ; Liu JH; Pu XP
    PLoS One; 2013; 8(10):e78220. PubMed ID: 24205164
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metformin lowers α-synuclein phosphorylation and upregulates neurotrophic factor in the MPTP mouse model of Parkinson's disease.
    Katila N; Bhurtel S; Shadfar S; Srivastav S; Neupane S; Ojha U; Jeong GS; Choi DY
    Neuropharmacology; 2017 Oct; 125():396-407. PubMed ID: 28807678
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gami-Chunggan Formula Prevents Motor Dysfunction in MPTP/p-Induced and A53T α-Synuclein Overexpressed Parkinson's Disease Mouse Model Though DJ-1 and BDNF Expression.
    Ahn S; Liu QF; Jang JH; Park J; Jeong HJ; Kim Y; Kim DH; Jeong G; Oh ST; Park SU; Cho SY; Park HJ; Jeon S
    Front Aging Neurosci; 2019; 11():230. PubMed ID: 31555122
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Piperine promotes PI3K/AKT/mTOR-mediated gut-brain autophagy to degrade α-Synuclein in Parkinson's disease rats.
    Yu L; Hu X; Xu R; Zhao Y; Xiong L; Ai J; Wang X; Chen X; Ba Y; Xing Z; Guo C; Mi S; Wu X
    J Ethnopharmacol; 2024 Mar; 322():117628. PubMed ID: 38158101
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decrease in
    Han S; Seo MH; Lim S; Yeo S
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884422
    [TBL] [Abstract][Full Text] [Related]  

  • 30. α-Synuclein BAC transgenic mice exhibit RBD-like behaviour and hyposmia: a prodromal Parkinson's disease model.
    Taguchi T; Ikuno M; Hondo M; Parajuli LK; Taguchi K; Ueda J; Sawamura M; Okuda S; Nakanishi E; Hara J; Uemura N; Hatanaka Y; Ayaki T; Matsuzawa S; Tanaka M; El-Agnaf OMA; Koike M; Yanagisawa M; Uemura MT; Yamakado H; Takahashi R
    Brain; 2020 Jan; 143(1):249-265. PubMed ID: 31816026
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Geniposide reduces α-synuclein by blocking microRNA-21/lysosome-associated membrane protein 2A interaction in Parkinson disease models.
    Su C; Yang X; Lou J
    Brain Res; 2016 Aug; 1644():98-106. PubMed ID: 27173998
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of Potential Neuroprotective Effects of Vanillin Against MPP
    Rani L; Ghosh B; Ahmad MH; Mondal AC
    Mol Neurobiol; 2023 Aug; 60(8):4693-4715. PubMed ID: 37145378
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuroprotective effects of extract of Acanthopanax senticosus harms on SH-SY5Y cells overexpressing wild-type or A53T mutant α-synuclein.
    Li XZ; Zhang SN; Wang KX; Liu HY; Yang ZM; Liu SM; Lu F
    Phytomedicine; 2014 Apr; 21(5):704-11. PubMed ID: 24252343
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treadmill exercise produces neuroprotective effects in a murine model of Parkinson's disease by regulating the TLR2/MyD88/NF-κB signaling pathway.
    Koo JH; Jang YC; Hwang DJ; Um HS; Lee NH; Jung JH; Cho JY
    Neuroscience; 2017 Jul; 356():102-113. PubMed ID: 28527958
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Roflupram protects against rotenone-induced neurotoxicity and facilitates α-synuclein degradation in Parkinson's disease models.
    Dong WL; Zhong JH; Chen YQ; Xie JF; Qin YY; Xu JP; Cai NB; Li MF; Liu L; Wang HT
    Acta Pharmacol Sin; 2021 Dec; 42(12):1991-2003. PubMed ID: 34531546
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutational analysis of SYNJ1 gene (PARK20) in Parkinson's disease in a Taiwanese population.
    Chen KH; Wu RM; Lin HI; Tai CH; Lin CH
    Neurobiol Aging; 2015 Oct; 36(10):2905.e7-8. PubMed ID: 26149920
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel fatty acid-binding protein 3 ligand inhibits dopaminergic neuronal death and improves motor and cognitive impairments in Parkinson's disease model mice.
    Haga H; Yamada R; Izumi H; Shinoda Y; Kawahata I; Miyachi H; Fukunaga K
    Pharmacol Biochem Behav; 2020 Apr; 191():172891. PubMed ID: 32126223
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GM1 Ganglioside Modifies α-Synuclein Toxicity and is Neuroprotective in a Rat α-Synuclein Model of Parkinson's Disease.
    Schneider JS; Aras R; Williams CK; Koprich JB; Brotchie JM; Singh V
    Sci Rep; 2019 Jun; 9(1):8362. PubMed ID: 31182727
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Effects of Novel Formulations of Edaravone and Curcumin in the Mouse Intrastriatal Lipopolysaccharide Model of Parkinson's Disease.
    Deng I; Garg S; Zhou XF; Bobrovskaya L
    Front Biosci (Schol Ed); 2022 May; 14(2):13. PubMed ID: 35730438
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-214 participates in the neuroprotective effect of Resveratrol via inhibiting α-synuclein expression in MPTP-induced Parkinson's disease mouse.
    Wang ZH; Zhang JL; Duan YL; Zhang QS; Li GF; Zheng DL
    Biomed Pharmacother; 2015 Aug; 74():252-6. PubMed ID: 26349993
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.